H2020-SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications

OBJECTIVES OF THE FUNDING PROGRAMME: Proposals are expected to strengthen the Europe’s position in regenerative therapies. Actions must aim to develop new regenerative therapies based on new approaches (e.g. genome editing or gene therapy, transdifferentiation or in vivo reprogramming, cell therapy and transplantation, 3D bioprinting, organoids or use of combined products) to address unmet clinical needs. The project may focus on any step(s) on the innovation chain, from early testing and characterization of regenerative mechanisms to preclinical research.